Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Can-Fite Biopharma Ltd ADR (CANF)

Can-Fite Biopharma Ltd ADR (CANF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Can-Fite Biopharma Ltd ADR 10 BAREKET STREET KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 ISR

P: 972-3924-1114

Description:

Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.

Key Statistics

Overview:

Market Capitalization, $K 26,439
Shares Outstanding, K 21,532
Annual Sales, $ 760 K
Annual Net Income, $ -14,440 K
Last Quarter Sales, $ 250 K
Last Quarter Net Income, $ -3,220 K
60-Month Beta 1.86
% of Institutional Shareholders 2.17%
Float, K 21,532
% Float 100.00%

Growth:

1-Year Return -32.53%
3-Year Return -93.85%
5-Year Return -96.28%
5-Year Revenue Growth 347.06%
5-Year Earnings Growth 80.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/29/21
Earnings Per Share ttm -0.85
EPS Growth vs. Prev Qtr -58.33%
EPS Growth vs. Prev Year 36.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/10/19

CANF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -7.88
Price/Earnings to Growth N/A
Return-on-Equity % -169.69%
Return-on-Assets % -99.89%
Profit Margin % -1,900.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales 34.43
Price/Cash Flow N/A
Price/Book 5.30
Book Value/Share 0.23
Interest Coverage -47.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar